China NMPA Drug Inspection - Kunming Jingtian Pharmaceutical Co., Ltd. - Drynaria fortunei
China NMPA drug inspection for Kunming Jingtian Pharmaceutical Co., Ltd. published December 29, 2020. Drug: Drynaria fortunei. The Guizhou Provincial Drug Administration published its fourth Drug Quality Announcement of 2020 on December 29, 2020,
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Kunming Jingtian Pharmaceutical Co., Ltd. published December 29, 2020. Drug: Drynaria fortunei. The Guizhou Provincial Drug Administration published its fourth Drug Quality Announcement of 2020 on December 29, 2020,
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox